Silver Book Fact

Around 75 – 100 experimental therapies that are aimed at slowing or stopping the progression of Alzheimer’s disease are currently in clinical trials.

Alzheimer's Association. 2011 Alzheimer’s Disease Facts and Figures. Alzheimers Dement. 2011; 7(2): 208-44. http://www.alzheimersanddementia.com/article/S1552-5260(11)00036-7/fulltext

Reference

Title
2011 Alzheimer’s Disease Facts and Figures
Publication
Alzheimers Dement
Publication Date
2011
Authors
Alzheimer's Association
Volume & Issue
Volume 7, Issue 2
Pages
208-44
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • An Alzheimer’s disease treatment breakthrough that slowed its progression and began to show its effects in 2015, would reduce the Medicare costs for people with the disease by $20 billion…  
  • An Alzheimer’s disease treatment breakthrough that slowed its progression and began to show its effects in 2015, would reduce the total costs of care for people with the disease by…  
  • If an Alzheimer’s disease treatment breakthrough that delayed the age of onset by 5 years was introduced in 2015, by 2020 out-of-pocket costs to individuals and families dealing with the…  
  • Donepezil, a new Alzheimer’s medication, increased prescription costs to $1,000 per patient, however the overall health care costs decreased from $11,947 to $8,056.  
  • A recent study showed that memantine, a medicine approved to treat moderate-to-severe Alzheimer’s, significantly slows cognitive decline and reduces the need for caregiving by 45.8 hours per month.